Outstanding swiss and international start-ups and SME’s presented yesterday their business projects at the 2nd round of the Swiss Innovation Challenge.  

 

The Swiss Innovation Challenge (SIC) is an innovation promotion program in which 25 finalists and one winner are selected from over 100 innovation projects in three elimination rounds. The participants in the competition are SMEs and start-ups from around the globe. SIC offers attractive awards and a unique 8-month acceleration program. Furthermore, it helps participants to build a concrete path towards recognition and business success. They benefit from individual coaching, tailored education, and extensive mentoring. This is a very important point for the participants, as they can get easier access to sponsors and potential business partners.

Over the last two days, the second pitch of SIC 2020 has taken place at the University of Applied Sciences and Arts Northwestern Switzerland. The 50 selected participants from the last round have presented their innovative projects in front of a very experienced jury. This second round has been very successful. Following safety guidelines to help prevent the spread of COVID-19, all participants and the jury wore face masks. The contestants presented (online and on-site) their projects with great enthusiasm to the jury.  

In this 6th edition, Hemex is supporting this Challenge with a special prize in the “Life Sciences” category. We were also very honored to be part of the jury for the first time. The participants’ devotion to their projects motivates us to continue working in the development of innovative solutions for the healthcare industry. Overall, 25 ventures will make it to the next stage and pitch in the 3rd round of this challenge. We would like to wish all start-ups the very best of luck! The award ceremony will take place in November.

 

About Hemex

HEMEX AG is a privately-owned Swiss investment and consulting company headquartered close to the Basel global life sciences hub. Its primary focus is to bring innovative drugs, medical devices, and in–vitro diagnostics to the market. HEMEX specializes in supporting early-stage start-ups, offering tailored solutions to accelerate projects into successful and sustainable businesses. Additionally, HEMEX helps and supports start-ups to find non-dilutive and dilutive funding. More at HEMEX.

Leave a Reply

Your email address will not be published. Required fields are marked *